Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Jan 21 2000
WASHINGTON, D.C. (Jan. 21, 1999) Not too long ago, the idea of treating the root causes of diseases was just that, an idea. And so was the prospect of feeding...
Jan 20 2000
CEO & Investor Conference To Showcase Industry To New Investors WASHINGTON, D.C. (January 20, 2000) Recent gains inbiotechnology stocks have rivaled the...
Jan 18 2000
WASHINGTON, D.C. (January 14, 2000) A BIO-sponsored television ad will begin running Jan. 17 on cable and news talk shows throughout the Washington...
Jan 18 2000
WASHINGTON, D.C. (Jan. 18, 2000) Another 22biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug...
Jan 11 2000
Washington, D.C. (January 11, 2000) The Biotechnology Industry Organization (BIO) will host its 14th International Biotechnology Meeting and Exhibition two...
Dec 20 1999
WASHINGTON, D.C. (Dec. 20, 1999) -- Dr. Judah Folkman, who discovered the process of tumor angiogenesis, and Dr. Jurgen Drews, former president of global...
Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient...
Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech): Washington, D.C. (December 6,...
Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's...


Biotechnology News

September 2, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

September 2, 2014

NEW YORK--(BUSINESS WIRE)--David R. Guyer, M.D., CEO of Ophthotech Corp. will present an overview of the Company at the Morgan Stanley Global Healthcare Conference in New...

September 2, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the closing of a $16 million Series B financing to fund continued development of its proprietary...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal...

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman...